SAMUEL MOSKOWITZ: Open Payments
NPI 1932336161 · EDENTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$491 in 26 payments from 11 companies in 2025. Trend: 2023 $434 · 2024 $538 · 2025 $491
Food & beverage: $491
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $89 |
| ABBVIE INC. | 4 | $88 |
| Novo Nordisk Inc | 3 | $64 |
| Endo USA, Inc. | 2 | $50 |
| Corcept Therapeutics | 2 | $49 |
| Amgen Inc. | 3 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $30 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| Eisai Inc. | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $20 |
Products named: VRAYLAR, ELIQUIS, Korlym, OTEZLA, PREVNAR 20, JARDIANCE, AVEED, Wegovy.
Industry payments across NC — which companies pay providers there.
